ALT 0.00% 0.5¢ analytica limited

The chairman was particularly vague on this always stating 2016...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 134 Posts.
    lightbulb Created with Sketch. 4
    The chairman was particularly vague on this always stating 2016 and not being specific as to when in 2016.. You have to remember the clinical trial is being conducted by a independent 3rd party so ALT have no say or influence over the trial, recruitment process or end date.. I got from the AGM that the initial trial is around efficacy of the product however there seems to be a 2nd end point for sexual dysfunction which may be closer to end of 2016...

    Also a very interesting point made was that the baseline or control group in the CT is a group of women who instead of using the pericoach are getting specific individual supervised training on PFE monitored directly by a specialist clinician and that group then have monthly meetings with the clinician to ensure PFE are being done correctly. So the Pericoach results will be measured against that control group -
 
watchlist Created with Sketch. Add ALT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.